A private equity fund operator, ‘H&Q,’ takes over Ildong Pharmaceutical’s shares owned by Green Cross

H&Q Korea, a domestic private equity fund operator, will become the 2^nd largest shareholder of Ildong Pharmaceutical as purchasing closely 25% of its shares owned by Green Cross, the former 2^nd largest shareholder.

On the 24^th, the Korea Economic Daily reported a confirmation that the Ildong Pharmaceutical’s largest shareholders, such as President Won-young Yoon, have selected H&Q Korea as the...